LEADER 03469oam  2200625I  450 
001 9910786761003321
005 20230807211154.0
010   $a0-429-07353-4
010   $a1-4665-9948-0
024 7 $a10.1201/b17271 
035   $a(CKB)3710000000218324
035   $a(EBL)1561194
035   $a(SSID)ssj0001289396
035   $a(PQKBManifestationID)11949750
035   $a(PQKBTitleCode)TC0001289396
035   $a(PQKBWorkID)11308397
035   $a(PQKB)10326902
035   $a(OCoLC)891397579
035   $a(MiAaPQ)EBC1561194
035   $a(OCoLC)890721120
035   $a(EXLCZ)993710000000218324
100   $a20180331h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aNanotechnology and drug delivery /$feditor, Professor Dr. Jose L. Arias, Department of Pharmacy and Pharmaceutical Technology Faculty of Pharmacy University of Granada Campus Universitario de Cartuja s/n, 18071 Granada, Spain
210  1$aBoca Raton :$cCRC Press,$d[2015]
210  4$dİ2015
215   $a1 online resource (378 p.)
300   $aDescription based upon print version of record.
311   $a1-322-63630-3 
311   $a1-4665-9947-2 
320   $aIncludes bibliographical references and index.
327   $aFront Cover; Preface to The Book Series; Preface to Volume 1; Contents; CHAPTER 1: Key Aspects in Nanotechnology and Drug Delivery; CHAPTER 2: Drug Delivery and Release from Polymeric Nanomaterials; CHAPTER 3: Nano-Sized Polymeric Drug Carrier Systems; CHAPTER 4: Reversible Cross-Linked Polymeric Nanoplatform in Drug Delivery; CHAPTER 5: Cyclodextrins in Drug Delivery; CHAPTER 6: Drug Delivery Systems Based on Tyrosine-derived Nanospheres (TyroSpheresTM); CHAPTER 7: Carbon Nanotubes for Drug Delivery Applications; CHAPTER 8: Metallic Nanoparticulate Drug Delivery Systems
327   $aCHAPTER 9: Porous Silica Nanoparticles for Drug Delivery and Controlled ReleaseCHAPTER 10: Iron Oxides in Drug Delivery; CHAPTER 11: Nanoengineered Magnetic Field-Induced Targeted Drug Delivery System with Stimuli-Responsive Release; Color Plate Section; Back Cover
330   $aPharmacotherapy is often limited by the inefficient activity and severe toxicity of drug molecules. Nanotechnology offers a revolutionary and definitive approach for the efficient delivery of drug molecules to non-healthy tissues and cells. This first volume of a series of two volumes analyzes the basics in the development of drug-loaded nanoplatforms, the so-called nanomedicines. Special attention is given to physicochemical engineering, pharmacokinetics, biocompatibility and biodegradability, representative nanoplatforms (based on lipids, polymers, cyclodextrins, metals, carbon, silica, iron oxides, et cetera), and advanced nano-engineering strategies for passive, ligand-mediated, and/or stimuli-sensitive drug delivery and release--Provided by publisher.
606   $aDrug delivery systems
606   $aNanoparticles
606   $aDrugs$xDesign
606   $aNanotechnology
615  0$aDrug delivery systems.
615  0$aNanoparticles.
615  0$aDrugs$xDesign.
615  0$aNanotechnology.
676   $a620.1/18
676   $a620.118
702   $aArias$b Jose L.
801  0$bFlBoTFG
801  1$bFlBoTFG
906   $aBOOK
912   $a9910786761003321
996   $aNanotechnology and drug delivery$93806710
997   $aUNINA